Cervical cancer screening is crucial for the early detection and prevention of cervical cancer, with the pap smear test being the primary screening tool used in Malaysia and globally.
The pap smear test helps detect abnormal cells in the cervix, including conditions such as atypical squamous cells of Atypical Squamous Cells of Undetermined Significance (ASCUS) and other precancerous cells that may develop into cervical cancer if left untreated.
A major cause of cervical cancer is human papillomavirus (HPV) infection. As such, a combination of HPV testing and pap smear screening plays a critical role in identifying potential risk at an early stage.
A pap smear is a simple yet vital screening procedure that helps detect early cellular changes in the cervix. These abnormal changes may progress into cervical cancer over time, making early detection essential for effective treatment.
The pap smear test significantly reduces the risk of developing cervical cancer by identifying abnormal cells before they become cancerous. Early detection allows for timely intervention, which improves long-term outcomes.
According to pap smear screening guidelines, women aged 21 to 65 should undergo regular testing. The frequency of testing may vary depending on a woman’s age, medical history, and personal risk factors.
For women aged 30 and above, the HPV DNA test may be performed in conjunction with the pap smear test to provide more accurate screening results and reduce the likelihood of false negatives.
All women aged 21 to 65 who are sexually active are encouraged to undergo regular pap smear screening, regardless of sexual history or perceived risk level. Women with a family history of cervical cancer, or those who have had abnormal pap smear results in the past, may require more frequent testing and closer follow-up.
Pap smear screening is also important for women with a prior diagnosis of cervical intraepithelial neoplasia (CIN) or those who have been advised of abnormal cells during past tests. Women who are HIV-positive or who have a weakened immune system should follow more stringent screening schedules as they are at higher risk for cervical abnormalities.
To ensure the most accurate results, women preparing for a pap smear test should:
The pap smear test is a straightforward and quick procedure usually conducted during a routine clinic visit. An instrument called a speculum is gently inserted into the vagina to provide a clear view of the cervix. A small brush or spatula is then used to collect cell samples from the cervix.
While the test is generally painless, some women may experience mild discomfort or cramping during the procedure. The entire process usually takes just a few minutes. The cell samples are sent to a laboratory for examination, and most test results are available within a few days. Patients are advised to follow up with their doctor to discuss the results.
Pap smear results are usually categorised as normal, abnormal, or unclear. Your doctor will help explain what each result means and whether any further testing is needed.
If abnormal results are found, it may indicate precancerous cells or early stages of cervical cancer. Depending on the findings, your doctor may recommend a repeat test, HPV testing, or a colposcopy for closer examination.
Patients with abnormal results are encouraged to ask questions about the severity and type of cell changes, and understand the available treatment or follow-up plans. Timely follow-up is critical in managing cervical health effectively and preventing further complications.
A pap smear is a test that checks for abnormal cell changes in the cervix. It is the most effective method to detect early signs of cervical cancer before symptoms appear.
Women aged 21 – 65 should have a pap smear every 3 years, or every 5 years if combined with HPV testing, unless advised otherwise by a doctor.
HPV infection is the main risk factor. Safe sexual practices, regular screenings, and HPV vaccination can significantly lower your risk.
In early stages, cervical cancer may have no symptoms. In later stages, symptoms may include abnormal bleeding, pelvic pain, or discharge. It is diagnosed through screening and confirmed via biopsy, with treatment ranging from monitoring to surgery or radiation.
It is best to avoid scheduling the test during your period. Refrain from intercourse or using vaginal products 24 – 48 hours before the test for the most accurate results.
Monday – Friday:
9:00am to 5:00pm
Saturday:
9:00am to 1:00pm
Sunday and Public Holiday:
Closed
For your convenience, we accept payments via cash or credit cards.
For other credit card instalments, kindly consult your respective banks.
If you have a Guarantee Letter (GL) from a panel insurance company, kindly proceed to our Business Office Counter.
Spread the love, follow us on our social media channels